Search Results

VX-809 25mg 25mg  | Purity Not Available

Adooq Bioscience

VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF).

More Information Supplier Page

VX-809 10mg 10mg  | Purity Not Available

Adooq Bioscience

VX-809 is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF).

More Information Supplier Page

VX-765 50mg 50mg  | Purity Not Available

Adooq Bioscience

VX-765 is a novel Caspase-1 inhibitor,which is an enzyme that controls the generation of two cytokines, IL-1b and IL-18.

More Information Supplier Page

VX-765 5mg 5mg  | Purity Not Available

Adooq Bioscience

VX-765 is a novel Caspase-1 inhibitor,which is an enzyme that controls the generation of two cytokines, IL-1b and IL-18.

More Information Supplier Page

Vorinostat 500mg 500mg  | Purity Not Available

Adooq Bioscience

Vorinostat is an inhibitor of HDACs, inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors.

More Information Supplier Page